Over-Representation of Recessive Osteogenesis Imperfecta in Asian Indian Children

Abstract

Several genes are implicated in the etiology of early onset osteogenesis imperfecta (OI). The various genes causing severe OI include WNT1, SERPINF1, P3H1, CREB3L1, and CRTAP, although glycine substitutions in COL1A1chains have also been predicted to cause perinatal lethal OI . Patients with early onset OI present decreased mobility, recurrent rib fractures, bony deformities, and chest infections that lead to an early death. We reported our experience in children with OI in Asian Indian families, which includes two patients with SERPINF1 pathogenic variants; and another two patients with severe OI and antenatal fractures caused by pathogenic variants in the CRTAP gene, identified by next generation sequencing (NGS). For one affected fetus, medical termination of pregnancy was done. The other baby was started on zoledronate therapy just after birth and is now 3 years old. Prenatal diagnosis was subsequently done on chorionic villus sample in the latter family.

Keywords

Brittle Bones - next generation sequencing - prolyl hydroxylation - recurrent fractures - zoledronate

Publication History

Received: 24 June 2020

Accepted: 17 August 2020

Article published online:
16 September 2020

• References

• 1 Barnes AM, Chang W, Morello R. et al. Deficiency of cartilage-associated protein in recessive lethal osteogenesis imperfecta. N Engl J Med 2006; 355 (26) 2757-2764
• 2 Morello R, Bertin TK, Chen Y. et al. CRTAP is required for prolyl 3- hydroxylation and mutations cause recessive osteogenesis imperfecta. Cell 2006; 127 (02) 291-304
• 3 Richards S, Aziz N, Bale S. et al; ACMG Laboratory Quality Assurance Committee. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 2015; 17 (05) 405-424
• 4 Kumar C, Panigrahi I, Somasekhara Aradhya A, Meena BL, Khandelwal N. Zoledronate for osteogenesis imperfecta: evaluation of safety profile in children. J Pediatr Endocrinol Metab 2016; 29 (08) 947-952
• 5 Panigrahi I, Didel S, Kirpal H. et al. Novel mutation in a family with WNT1-related osteoporosis. Eur J Med Genet 2018; 61 (07) 369-371
• 6 Forlino A, Marini JC. Osteogenesis imperfecta. Lancet 2016; 387 (10028): 1657-1671
• 7 Valli M, Barnes AM, Gallanti A. et al. Deficiency of CRTAP in non-lethal recessive osteogenesis imperfecta reduces collagen deposition into matrix. Clin Genet 2012; 82 (05) 453-459
• 8 Saraff V, Sahota J, Crabtree N, Sakka S, Shaw NJ, Högler W. Efficacy and treatment costs of zoledronate versus pamidronate in paediatric osteoporosis. Arch Dis Child 2018; 103 (01) 92-94
• 9 Balasubramanian M, Pollitt RC, Chandler KE. et al. CRTAP mutation in a patient with Cole-Carpenter syndrome. Am J Med Genet A 2015; 167A [phone]
• 10 Amor IM, Rauch F, Gruenwald K. et al. Severe osteogenesis imperfecta caused by a small in-frame deletion in CRTAP. Am J Med Genet A 2011; 155A (11) 2865-2870
• 11 McClung MR. Sclerostin antibodies in osteoporosis: latest evidence and therapeutic potential. Ther Adv Musculoskelet Dis 2017; 9 (10) 263-270
• 12 Van Dijk FS, Nesbitt IM, Nikkels PGJ. et al. CRTAP mutations in lethal and severe osteogenesis imperfecta: the importance of combining biochemical and molecular genetic analysis. Eur J Hum Genet 2009; 17 (12) 1560-1569
• 13 Lin H-Y, Chuang C-K, Su Y-N. et al. Genotype and phenotype analysis of Taiwanese patients with osteogenesis imperfecta. Orphanet J Rare Dis 2015; 10: 152
• 14 Ho Duy B, Zhytnik L, Maasalu K. et al. Mutation analysis of the COL1A1 and COL1A2 genes in Vietnamese patients with osteogenesis imperfecta. Hum Genomics 2016; 10 (01) 27
• 15 Lee K-S, Song H-R, Cho T-J. et al. Mutational spectrum of type I collagen genes in Korean patients with osteogenesis imperfecta. Hum Mutat 2006; 27 (06) 599
• 16 Zhytnik L, Maasalu K, Reimann E, Prans E, Kõks S, Märtson A. Mutational analysis of COL1A1 and COL1A2 genes among Estonian osteogenesis imperfecta patients. Hum Genomics 2017; 11 (01) 19
• 17 Caparrós-Martin JA, Valencia M, Pulido V. et al. Clinical and molecular analysis in families with autosomal recessive osteogenesis imperfecta identifies mutations in five genes and suggests genotype-phenotype correlations. Am J Med Genet A 2013; 161A [phone]